GAMCO Investors’s Cidara Therapeutics CDTX Stock Holding History

GAMCO Investors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,500	Closed	-$2.76M	–	1017
2025 Q4	$2.76M	Buy	+12,500	New	+$2.02M	0.03%	476

GAMCO Investors's CDTX Position: Q1 2026 in Review

GAMCO Investors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 12,500 shares — an estimated $2.76M sold.

GAMCO Investors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $2.76M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

GAMCO Investors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
GAMCO Investors sold 12,500 Cidara Therapeutics shares in Q1 2026, an estimated $2.76M.
GAMCO Investors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
GAMCO Investors's Cidara Therapeutics position peaked at $2.76M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.